e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Science and biomarkers in TB
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods
Allison Wolf (New York, United States of America), Allison Wolf, Max O’Donnell, Paras Jain, Vanisha Munsamy, Farina Karim, Michelle Larsen, Alexander Pym, William R. Jacobs
Source:
International Congress 2015 – Science and biomarkers in TB
Session:
Science and biomarkers in TB
Session type:
Oral Presentation
Number:
3489
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Allison Wolf (New York, United States of America), Allison Wolf, Max O’Donnell, Paras Jain, Vanisha Munsamy, Farina Karim, Michelle Larsen, Alexander Pym, William R. Jacobs. Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods. Eur Respir J 2015; 46: Suppl. 59, 3489
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010
Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Identification of novel tuberculosis diagnostic biomarkers in plasma and saliva
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Biomarkers and VAP: results and perspectives
Source: Eur Respir Mon 2011; 53: 24-35
Year: 2011
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Evaluation of new biomarkers for laboratory diagnosis of tuberculosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Rapid detection of mycobacterial growth in in vitro cultures by VOC analysis
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Enhanced diagnosis of tuberculosis using a dual gene target detection approach
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016
Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019
Year: 2020
Characteristics of the new cases of the tuberculosis according to the method of screening
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Tuberculosis: update on new diagnostic methods and treatment approach
Source: Annual Congress 2007 - Infections year in review
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept